Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
Hum Reprod ; 34(12): 2456-2466, 2019 12 01.
Article in English | MEDLINE | ID: mdl-31825483

ABSTRACT

STUDY QUESTION: Are uterine natural killer (uNK) cell numbers and their distribution relative to endometrial arterioles altered in women with recurrent implantation failure (RIF) compared to women with embryo implantation success (IS)? SUMMARY ANSWER: uNK cell numbers and their distribution relative to endometrial arterioles are not significantly different in women with RIF compared to women in whom embryo implantation occurs successfully following IVF. WHAT IS ALREADY KNOWN: uNK cells are regulators of decidual angiogenesis and spiral arteriole remodelling during early pregnancy. Although some studies have shown that uNK cell numbers may be altered in women with RIF, the methods used to measure uNK cell numbers have proven inconsistent, making reproduction of these results difficult. It is unclear, therefore, whether the results reported so far are reproducible. Moreover, it is not known how uNK cell numbers may impact IVF outcomes. Despite the lack of conclusive evidence, uNK cell numbers are often evaluated as a prognostic criterion in women undergoing assisted reproductive procedures. STUDY DESIGN, SIZE, DURATION: Endometrial pipelle biopsies were collected 6-8 days post-LH surge in natural cycles from women with RIF (n = 14), women with IS (n = 11) and women with potential RIF at the time of the study (PRIF; n = 9) from 2013 to 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: uNK cells (i.e. CD56+ and/or CD16+ phenotypes) and their distribution relative to endometrial arterioles were investigated by standard immunohistochemistry protocols and quantified using Aperio ScanScopeXT images digitized by ImageJ and deconvoluted into binary images for single cell quantification using a Gaussian Blur and Yen algorithm. MAIN RESULTS AND THE ROLE OF CHANCE: There was no significant difference in the cell density of CD56+ or CD16+ uNK cells in women with RIF compared to women with IS or PRIF. There was a higher proportion of uNK cells in the distal regions compared to the regions closest to the arterioles in all patient groups. Further, we identified a significant reduction in uNK cell density in women who had a previous pregnancy compared to those who had not, regardless of their current implantation status. LARGE SCALE DATA: Not applicable. LIMITATIONS, REASONS FOR CAUTION: Spiral arterioles could not always be accurately identified by digital image analysis; therefore, all endometrial arterioles were selected and analysed. Patient numbers for the study were low. However, as the clinical phenotypes of each patient were well defined, and endometrial dating was accurately determined by three independent pathologists, differences between patient groups with respect to the uNK numbers and distribution should have been measurable if uNK cell counts were to be useful as a prognostic marker of RIF. WIDER IMPLICATIONS OF THE FINDINGS: Our findings demonstrate that CD56+ and CD16+ uNK cell numbers are not significantly different in women with RIF in a typical cohort of women undergoing IVF. Further, prior pregnancy was associated with a significantly reduced number of uNK cells in both the RIF and IS patient groups, suggestive of a long-term pregnancy induced suppression of uNK cells. Combined, these findings do not support the clinical value of using uNK cell numbers as a prognostic indicator of implantation success with IVF treatment. STUDY FUNDING/COMPETING INTEREST(S): Funding for this work was provided by Royal Women's Hospital Foundation. P.P. was supported by an NHMRC Early Career Fellowship [TF 11/14] and W.T.T. was supported by an NHMRC Postgraduate Scholarship [1055814]. The authors do not have any competing interests with this study.


Subject(s)
Embryo Implantation/immunology , Endometrium/immunology , Infertility, Female/immunology , Killer Cells, Natural , Adult , Arterioles/immunology , Endometrium/blood supply , Female , Humans , Pregnancy
2.
Part Fibre Toxicol ; 15(1): 43, 2018 11 09.
Article in English | MEDLINE | ID: mdl-30413212

ABSTRACT

BACKGROUND: The cardiovascular effects of pulmonary exposure to engineered nanomaterials (ENM) are poorly understood, and the reproductive consequences are even less understood. Inflammation remains the most frequently explored mechanism of ENM toxicity. However, the key mediators and steps between lung exposure and uterine health remain to be fully defined. The purpose of this study was to determine the uterine inflammatory and vascular effects of pulmonary exposure to titanium dioxide nanoparticles (nano-TiO2). We hypothesized that pulmonary nano-TiO2 exposure initiates a Th2 inflammatory response mediated by Group II innate lymphoid cells (ILC2), which may be associated with an impairment in uterine microvascular reactivity. METHODS: Female, virgin, Sprague-Dawley rats (8-12 weeks) were exposed to 100 µg of nano-TiO2 via intratracheal instillation 24 h prior to microvascular assessments. Serial blood samples were obtained at 0, 1, 2 and 4 h post-exposure for multiplex cytokine analysis. ILC2 numbers in the lungs were determined. ILC2s were isolated and phosphorylated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-ĸB) levels were measured. Pressure myography was used to assess vascular reactivity of isolated radial arterioles. RESULTS: Pulmonary nano-TiO2 exposure was associated with an increase in IL-1ß, 4, 5 and 13 and TNF- α 4 h post-exposure, indicative of an innate Th2 inflammatory response. ILC2 numbers were significantly increased in lungs from exposed animals (1.66 ± 0.19%) compared to controls (0.19 ± 0.22%). Phosphorylation of the transactivation domain (Ser-468) of NF-κB in isolated ILC2 and IL-33 in lung epithelial cells were significantly increased (126.8 ± 4.3% and 137 ± 11% of controls respectively) by nano-TiO2 exposure. Lastly, radial endothelium-dependent arteriolar reactivity was significantly impaired (27 ± 12%), while endothelium-independent dilation (7 ± 14%) and α-adrenergic sensitivity (8 ± 2%) were not altered compared to control levels. Treatment with an anti- IL-33 antibody (1 mg/kg) 30 min prior to nano-TiO2 exposure resulted in a significant improvement in endothelium-dependent dilation and a decreased level of IL-33 in both plasma and bronchoalveolar lavage fluid. CONCLUSIONS: These results provide evidence that the uterine microvascular dysfunction that follows pulmonary ENM exposure may be initiated via activation of lung-resident ILC2 and subsequent systemic Th2-dependent inflammation.


Subject(s)
Arterioles/drug effects , Immunity, Innate/drug effects , Lung/drug effects , Lymphocytes/drug effects , Nanoparticles/toxicity , Titanium/toxicity , Uterus/blood supply , Animals , Arterioles/immunology , Arterioles/physiopathology , Endothelium, Vascular/drug effects , Endothelium, Vascular/immunology , Female , Inhalation Exposure/adverse effects , Interleukin-33/blood , Lung/blood supply , Lung/immunology , Lymphocyte Count , Lymphocytes/immunology , Microcirculation/drug effects , Microcirculation/immunology , Rats, Sprague-Dawley , Vasodilation/drug effects , Vasodilation/immunology
3.
Blood ; 130(2): 192-204, 2017 07 13.
Article in English | MEDLINE | ID: mdl-28455282

ABSTRACT

Stem cell-derived platelets have the potential to replace donor platelets for transfusion. Defining the platelet-producing megakaryocytes (MKs) within the heterogeneous MK culture may help to optimize the in vitro generation of platelets. Using 2 human stem cell models of megakaryopoiesis, we identified novel MK populations corresponding to distinct maturation stages. An immature, low granular (LG) MK pool (defined by side scatter on flow cytometry) gives rise to a mature high granular (HG) pool, which then becomes damaged by apoptosis and glycoprotein Ib α chain (CD42b) shedding. We define an undamaged HG/CD42b+ MK subpopulation, which endocytoses fluorescently labeled coagulation factor V (FV) from the media into α-granules and releases functional FV+CD42b+ human platelet-like particles in vitro and when infused into immunodeficient mice. Importantly, these FV+ particles have the same size distribution as infused human donor platelets and are preferentially incorporated into clots after laser injury. Using drugs to protect HG MKs from apoptosis and CD42b shedding, we also demonstrate that apoptosis precedes CD42b shedding and that apoptosis inhibition enriches the FV+ HG/CD42b+ MKs, leading to increased platelet yield in vivo, but not in vitro. These studies identify a transition between distinct MK populations in vitro, including one that is primed for platelet release. Technologies to optimize and select these platelet-ready MKs may be important to efficiently generate functional platelets from in vitro-grown MKs.


Subject(s)
Blood Platelets/cytology , Bone Marrow Cells/immunology , Factor V/genetics , Megakaryocyte Progenitor Cells/cytology , Megakaryocytes/cytology , Animals , Apoptosis/drug effects , Arterioles/drug effects , Arterioles/immunology , Arterioles/injuries , Biomarkers/blood , Blood Platelets/immunology , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Cell Differentiation , Cell Lineage/immunology , Endocytosis , Factor V/immunology , Factor V/pharmacology , Flow Cytometry , Gene Expression , Humans , Immunophenotyping , Lasers , Megakaryocyte Progenitor Cells/immunology , Megakaryocytes/immunology , Mice , Mice, SCID , Platelet Glycoprotein GPIb-IX Complex/genetics , Platelet Glycoprotein GPIb-IX Complex/immunology
4.
J Immunol ; 198(10): 4115-4128, 2017 05 15.
Article in English | MEDLINE | ID: mdl-28396316

ABSTRACT

Decidual spiral arteriole (SpA) remodeling is essential to ensure optimal uteroplacental blood flow during human pregnancy, yet very little is known about the regulatory mechanisms. Uterine decidual NK (dNK) cells and macrophages infiltrate the SpAs and are proposed to initiate remodeling before colonization by extravillous trophoblasts (EVTs); however, the trigger for their infiltration is unknown. Using human first trimester placenta, decidua, primary dNK cells, and macrophages, we tested the hypothesis that EVTs activate SpA endothelial cells to secrete chemokines that have the potential to recruit maternal immune cells into SpAs. Gene array, real-time PCR, and ELISA analyses showed that treatment of endothelial cells with EVT conditioned medium significantly increased production of two chemokines, CCL14 and CXCL6. CCL14 induced chemotaxis of both dNK cells and decidual macrophages, whereas CXCL6 also induced dNK cell migration. Analysis of the decidua basalis from early pregnancy demonstrated expression of CCL14 and CXCL6 by endothelial cells in remodeling SpAs, and their cognate receptors are present in both dNK cells and macrophages. Neutralization studies identified IL-6 and CXCL8 as factors secreted by EVTs that induce endothelial cell CCL14 and CXCL6 expression. This study has identified intricate crosstalk between EVTs, SpA cells, and decidual immune cells that governs their recruitment to SpAs in the early stages of remodeling and has identified potential key candidate factors involved. This provides a new understanding of the interactions between maternal and fetal cells during early placentation and highlights novel avenues for research to understand defective SpA remodeling and consequent pregnancy pathology.


Subject(s)
Arterioles/physiology , Decidua/physiology , Endothelial Cells/metabolism , Killer Cells, Natural/physiology , Macrophages/physiology , Trophoblasts/metabolism , Arterioles/cytology , Arterioles/immunology , Cell Movement/immunology , Cells, Cultured , Chemokine CXCL6/biosynthesis , Chemokine CXCL6/immunology , Chemokines, CC/biosynthesis , Chemokines, CC/immunology , Culture Media/chemistry , Decidua/immunology , Endothelial Cells/drug effects , Endothelial Cells/immunology , Female , Humans , Interleukin-6/immunology , Interleukin-6/metabolism , Interleukin-8/immunology , Interleukin-8/metabolism , Macrophages/immunology , Placenta/cytology , Placenta/immunology , Pregnancy , Pregnancy Trimester, First , Trophoblasts/immunology
5.
J Nutr Biochem ; 25(6): 642-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24746829

ABSTRACT

Dietary long-chain n-3 polyunsaturated fatty acids (LCn-3PUFA) improve endothelial function in medium-large-sized arteries, but effects on small peripheral arteries, responsible for most arterial resistance, are little known. We investigated the effects of increasing LCn-3PUFA intake with the usual diet on small artery reactive hyperemia index (saRHI). Within a clinical trial evaluating the effects of 1 year of intensive lifestyle intervention versus standard care on cardiovascular markers in subjects at risk, we selected 108 participants regardless of treatment allocation (n=47 standard care; n=61 intensive intervention) with complete baseline and follow-up information on dietary, clinical, saRHI and biochemical data, including biomarkers of inflammation and endothelial activation. At the end of follow-up, saRHI increased across tertiles of change in dietary LCn-3PUFA. Subjects in the top tertile (increased LCn-3PUFA intake) increased serum ApoA1 and decreased hs-CRP, serum TNF-α, sICAM-1, sVCAM-1 and oxLDL from baseline. After pooling data, in unadjusted models, changes in saRHI significantly correlated to changes in LCn-3PUFA intake and ApoA1 (directly) and changes in systolic blood pressure, waist circumference, TNF-α, sVCAM-1 and sE-selectin (inversely). In a multivariate model, changes in dietary LCn-3PUFA were significantly associated with changes in saRHI [B=0.08 (95% confidence interval=0.083-0.291) for an increase by 100 mg/day]. Systolic blood pressure was inversely associated with saRHI changes [B=-0.203 (-0.441 to -0.029) for a 9-mmHg increase]. We conclude that increased dietary consumption of LCn-3PUFA might be a cost-effective strategy to improve peripheral vasoactivity.


Subject(s)
Arterioles/physiopathology , Cardiovascular Diseases/prevention & control , Endothelium, Vascular/physiopathology , Fatty Acids, Omega-3/therapeutic use , Peripheral Arterial Disease/diet therapy , Adult , Aged , Arterioles/immunology , Biomarkers/blood , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Combined Modality Therapy , Diet, Mediterranean , Endothelium, Vascular/immunology , Fatty Acids, Omega-3/administration & dosage , Female , Follow-Up Studies , Humans , Hyperemia/etiology , Hyperemia/prevention & control , Life Style , Male , Middle Aged , Peripheral Arterial Disease/blood , Peripheral Arterial Disease/immunology , Peripheral Arterial Disease/physiopathology , Risk Factors , Severity of Illness Index , Spain/epidemiology , Vascular Resistance
6.
Z Gerontol Geriatr ; 47(5): 415-24, 2014 Jul.
Article in German | MEDLINE | ID: mdl-24271148

ABSTRACT

BACKGROUND: Whether and to what extent the complementary use of a biorhythm-defined physical stimulation of insufficient spontaneous arteriolar vasomotion contributes to increasing the therapeutic success of established treatment concepts were examined. MATERIALS AND METHODS: In a placebo-controlled study on a biometrically defined sample of older diabetes patients with impaired wound healing, measurements of representative features of the functional status of the microcirculation and the immune system were investigated using high-resolution methods (intravital microscopy, reflective spectrometry, white light spectroscopy combined with laser Doppler microflow measurements). The stimulation signal corresponding to physiological spontaneous arteriolar vasomotion was transmitted using an electromagnetic alternating field of low magnetic flux density. RESULTS: During the 27-day treatment and observation period, a complementary treatment effect of the applied biorhythm-defined physical vasomotion stimulation could be detected.


Subject(s)
Arterioles/immunology , Diabetic Angiopathies/immunology , Diabetic Angiopathies/therapy , Electric Stimulation Therapy/methods , Microcirculation/immunology , Wound Healing/immunology , Aged , Blood Flow Velocity/immunology , Combined Modality Therapy/methods , Diabetic Angiopathies/diagnosis , Female , Humans , Male , Musculoskeletal Manipulations/methods , Physical Stimulation/methods , Placebo Effect , Treatment Outcome
7.
Ophthalmic Plast Reconstr Surg ; 29(4): 290-3, 2013.
Article in English | MEDLINE | ID: mdl-23839635

ABSTRACT

PURPOSE: To delineate signals by which the vascular abnormalities inherent to ocular rosacea arise and to correlate these signals with elements of the innate immune system. METHODS: Experimental study. Immunohistochemical staining was performed for a variety of vascular markers and for toll-like receptor-4 on eyelid biopsies taken from patients with ocular rosacea and normal controls. Statistical comparisons were then performed between the 2 groups. RESULTS: Immunohistochemical staining for CD31 and integrin-ß-3 did not demonstrate any statistically significant differences between eyelids from patients with ocular rosacea and normal controls. Cutaneous biopsies from ocular rosacea patients demonstrated statistically significant enrichments of intercellular adhesion molecule-1 and CD105 among arterioles, whereas there were no statistically significant differences in the venules between normal controls and ocular rosacea patients. The correlation between the number of toll-like receptor-4-positive cells and each vascular marker was statistically significant. CONCLUSIONS: Cutaneous biopsies of the eyelid did not demonstrate an increase in the total number of blood vessels. However, the vascular abnormalities that are typical of ocular rosacea represent activated, inflamed vessels, and these phenomena may be mediated by intercellular adhesion molecule and CD105. Furthermore, the strong correlations between toll-like receptor-4 and each vascular marker suggest that the innate immune system may govern the cutaneous effects of ocular rosacea. Intercellular adhesion molecule, CD105, and toll-like receptor-4 may represent important therapeutic targets in the management of this disease.


Subject(s)
Eyelid Diseases/pathology , Eyelids/blood supply , Rosacea/pathology , Toll-Like Receptor 4/metabolism , Antigens, CD/metabolism , Arterioles/immunology , Arterioles/pathology , Biomarkers/metabolism , Case-Control Studies , Endoglin , Endothelium, Vascular/immunology , Endothelium, Vascular/pathology , Eyelid Diseases/immunology , Female , Humans , Immunity, Innate , Integrin beta3/analysis , Intercellular Adhesion Molecule-1/metabolism , Male , Middle Aged , Platelet Endothelial Cell Adhesion Molecule-1/analysis , Receptors, Cell Surface/metabolism , Rosacea/immunology , Venules/immunology , Venules/pathology
8.
Transplantation ; 96(2): 217-23, 2013 Jul 27.
Article in English | MEDLINE | ID: mdl-23698598

ABSTRACT

BACKGROUND: The mechanism of kidney injury in hematopoietic stem cell transplantation (HSCT)-associated thrombotic microangiopathy (TA-TMA) is not completely understood. Renal C4d staining is a marker of classic complement activation and endothelial injury and has been described in preliminary reports of HSCT recipients with TA-TMA. Our objective was to evaluate complement in the pathogenesis of small vessel injury in children receiving HSCT. We hypothesized that kidney tissue from children with TA-TMA would more frequently show C4d deposition compared with HSCT recipients without histologic TA-TMA. METHODS: We reviewed kidney specimens (biopsy or autopsy) from children who had undergone HSCT at a single center. Using histologic criteria alone, subjects were divided into TA-TMA (n = 8) and non-TA-TMA (control) groups (n = 12). C4d staining was performed by immunohistochemistry and evaluated on arterioles, peritubular capillaries, glomeruli, and tubular basement membranes. RESULTS: Diffuse or focal renal arteriolar C4d staining was more common in subjects with histologic TA-TMA (75%) compared with controls (8%). Rare peritubular capillary C4d staining was present in 50% of TA-TMA samples and was absent in controls. Glomerular C4d staining was seen at a similar frequency in cases and controls, whereas tubular basement membrane staining was less frequently observed and only in subjects with TA-TMA. CONCLUSIONS: Arteriolar C4d deposition may be a pathologic marker of TA-TMA, implicating localized complement fixation in HSCT recipients with kidney disease secondary to small vessel injury. Further studies to better characterize the preferential arteriolar C4d staining may identify a renal compartment of injury, possibly explaining the dramatic hypertension seen in TA-TMA.


Subject(s)
Complement C4b/metabolism , Hematopoietic Stem Cell Transplantation/adverse effects , Kidney/injuries , Peptide Fragments/metabolism , Thrombotic Microangiopathies/etiology , Adolescent , Arterioles/immunology , Arterioles/pathology , Biomarkers/metabolism , Capillaries/immunology , Capillaries/pathology , Case-Control Studies , Child , Child, Preschool , Female , Humans , Infant , Kidney/blood supply , Kidney/immunology , Male , Thrombotic Microangiopathies/immunology , Thrombotic Microangiopathies/pathology
9.
Nat Immunol ; 14(1): 41-51, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23179077

ABSTRACT

Coordinated navigation within tissues is essential for cells of the innate immune system to reach the sites of inflammatory processes, but the signals involved are incompletely understood. Here we demonstrate that NG2(+) pericytes controlled the pattern and efficacy of the interstitial migration of leukocytes in vivo. In response to inflammatory mediators, pericytes upregulated expression of the adhesion molecule ICAM-1 and released the chemoattractant MIF. Arteriolar and capillary pericytes attracted and interacted with myeloid leukocytes after extravasating from postcapillary venules, 'instructing' them with pattern-recognition and motility programs. Inhibition of MIF neutralized the migratory cues provided to myeloid leukocytes by NG2(+) pericytes. Hence, our results identify a previously unknown role for NG2(+) pericytes as an active component of innate immune responses, which supports the immunosurveillance and effector function of extravasated neutrophils and macrophages.


Subject(s)
Intercellular Adhesion Molecule-1/metabolism , Intramolecular Oxidoreductases/metabolism , Leukocytes/immunology , Macrophage Migration-Inhibitory Factors/metabolism , Pericytes/immunology , Receptors, Pattern Recognition/immunology , Antibodies, Blocking/pharmacology , Arterioles/immunology , Capillaries/immunology , Cell Communication/drug effects , Cell Movement/drug effects , Cell Movement/immunology , Cells, Cultured , Humans , Immunity, Innate , Inflammation Mediators/metabolism , Intercellular Adhesion Molecule-1/genetics , Intramolecular Oxidoreductases/genetics , Intramolecular Oxidoreductases/immunology , Leukocytes/drug effects , Macrophage Migration-Inhibitory Factors/genetics , Macrophage Migration-Inhibitory Factors/immunology , Neutrophil Activation/drug effects , Up-Regulation/drug effects , Venules/immunology
10.
Blood ; 120(20): 4246-55, 2012 Nov 15.
Article in English | MEDLINE | ID: mdl-23012327

ABSTRACT

Chemokines regulate the migration of hemopoietic cells and play an important role in the pathogenesis of many immune-mediated diseases. Intradermal recruitment of CD8(+) T cells by CXCL10 is a central feature of the pathogenesis of cutaneous acute GVHD (aGVHD), but very little is known about the pathogenesis of chronic GVHD (cGVHD). Serum concentrations of the 3 CXCR3-binding chemokines, CXCL9, CXCL10, and CXCL11, were found to be markedly increased in patients with active cGVHD of the skin (n = 8). An 80% decrease in CD4(+) cells expressing CXCR3 was seen in the blood of these patients (n = 5), whereas CD4(+) cells were increased in tissue biopsies and were clustered around the central arterioles of the dermis. The well-documented increase in expression of CXCL10 in aGVHD therefore diversifies in cGVHD to include additional members of the CXCR3-binding family and leads to preferential recruitment of CD4(+) T cells. These observations reveal a central role for chemokine-mediated recruitment of CXCR3(+) T cells in cGVHD.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Chemokine CXCL10/physiology , Chemokine CXCL11/physiology , Chemokine CXCL9/physiology , Graft vs Host Disease/immunology , Receptors, CXCR3/physiology , Acute Disease , Arterioles/immunology , Chemokine CXCL10/blood , Chemokine CXCL11/blood , Chemokine CXCL9/blood , Chemotaxis, Leukocyte , Dermis/blood supply , Dermis/immunology , Dermis/pathology , Disease Progression , Graft vs Host Disease/blood , Graft vs Host Disease/pathology , Hematologic Neoplasms/surgery , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Transplantation Conditioning
11.
Arterioscler Thromb Vasc Biol ; 32(11): 2702-10, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22922958

ABSTRACT

OBJECTIVE: The regulation of vascular permeability, leukocyte trafficking, and the integrity of endothelial cell-cell contacts are closely linked by a complex mechanism of interregulation. Here, we investigate the role of Krev interaction-trapped 1 (KRIT1), an adherens junction accessory protein required for cell-cell junction stability, in regulating these vascular functions. METHODS AND RESULTS: Krit1(+/-) mice exhibited an enhanced edematous response to the complex inflammatory stimuli found in the passive K/BxN model of inflammatory arthritis and the murine air pouch model, yet leukocyte infiltration was unchanged. Correspondingly, reduced KRIT1 expression increased baseline arteriole and venule permeability 2-fold over that of wild-type littermates, as measured by intravital microscopy of the intact cremaster muscle vascular network, but this increase was not accompanied by increased leukocyte extravasation or activation. Direct stimulation with tumor necrosis factor-α induced increased permeability in wild-type mice, but surprisingly no increase over baseline levels was observed in Krit1(+/-) mice, despite extensive leukocyte activation. Finally, adoptive transfer of Krit1(+/-) bone marrow failed to increase permeability in wild-type mice. However, reduced expression of KRIT1 in the hematopoietic lineage dampened the differences observed in baseline permeability. CONCLUSIONS: Taken together, our data indicate an integral role for KRIT1 in microvessel homeostasis and the vascular response to inflammation.


Subject(s)
Arterioles/metabolism , Arthritis/metabolism , Capillary Permeability , Edema/metabolism , Microtubule-Associated Proteins/deficiency , Proto-Oncogene Proteins/deficiency , Venules/metabolism , Animals , Arterioles/immunology , Arthritis/genetics , Arthritis/immunology , Arthritis/pathology , Bone Marrow Transplantation , Cells, Cultured , Disease Models, Animal , Down-Regulation , Edema/genetics , Edema/immunology , Edema/pathology , Homeostasis , Humans , Inflammation Mediators/metabolism , Joints/immunology , Joints/metabolism , Joints/pathology , KRIT1 Protein , Leukocyte Rolling , Leukocytes/immunology , Leukocytes/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Time Factors , Transfection , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation , Venules/immunology
12.
Am J Physiol Heart Circ Physiol ; 302(3): H567-81, 2012 Feb 01.
Article in English | MEDLINE | ID: mdl-22081707

ABSTRACT

We hypothesized that postcapillary venules play a central role in the control of the tightness of the coronary system as a whole, particularly under inflammatory conditions. Sandwich cultures of endothelial cells and pericytes of precapillary arteriolar or postcapillary venular origin from human myocardium as models of the respective vascular walls (sandwich cultures of precapillary arteriolar or postcapillary venular origin) were exposed to thrombin and components of the acutely activatable inflammatory system, and their hydraulic conductivity (L(P)) was registered. L(P) of SC-PAO remained low under all conditions (3.24 ± 0.52·10(-8)cm·s(-1)·cmH(2)O(-1)). In contrast, in the venular wall model, PGE(2), platelet-activating factor (PAF), leukotriene B(4) (LTB(4)), IL-6, and IL-8 induced a prompt, concentration-dependent, up to 10-fold increase in L(P) with synergistic support when combined. PAF and LTB(4) released by metabolically cooperating platelets, and polymorphonuclear leucocytes (PMNs) caused selectively venular endothelial cells to contract and to open their clefts widely. This breakdown of the barrier function was preventable and even reversible within 6-8 h by the presence of 50 µM quercetin glucuronide (QG). LTB(4) synthesis was facilitated by biochemical involvement of erythrocytes. Platelets segregated in the arterioles and PMNs in the venules of blood-perfused human myocardium (histological studies on donor hearts refused for heart transplantation). Extrapolating these findings to the coronary microcirculation in vivo would imply that the latter's complex functionality after accumulation of blood borne inflammatory mediators can change rapidly due to selective breakdown of the postcapillary venular barrier. The resulting inflammatory edema and venulo-thrombosis will severely impair myocardial performance. The protection afforded by QG could be of particular relevance in the context of cardiosurgical intervention.


Subject(s)
Blood Proteins/pharmacology , Capillary Permeability/immunology , Coronary Circulation/immunology , Endothelial Cells , Inflammation Mediators/pharmacology , Myocarditis/metabolism , Actins/metabolism , Arterioles/drug effects , Arterioles/immunology , Arterioles/metabolism , Blood Platelets/cytology , Blood Platelets/drug effects , Blood Platelets/metabolism , Capillaries/drug effects , Capillaries/immunology , Capillaries/metabolism , Capillary Permeability/drug effects , Cells, Cultured , Coronary Circulation/drug effects , Dinoprostone/pharmacology , Drug Synergism , Endothelial Cells/cytology , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Erythrocytes/cytology , Erythrocytes/drug effects , Erythrocytes/metabolism , Hemostatics/pharmacology , Humans , Interleukin-6/pharmacology , Interleukin-8/pharmacology , Leukotriene B4/pharmacology , Myocarditis/immunology , Pericytes/drug effects , Pericytes/immunology , Pericytes/metabolism , Platelet Activating Factor/pharmacology , Thrombin/pharmacology , Venules/drug effects , Venules/immunology , Venules/metabolism
13.
Basic Clin Pharmacol Toxicol ; 110(1): 70-2, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21740527

ABSTRACT

Low-grade inflammation plays a role in cardiovascular disease. The innate and the adaptive immune responses participate in mechanisms that contribute to inflammatory responses. It has been increasingly appreciated that different subsets of lymphocytes and the cytokines they produce modulate the vascular remodelling that occurs in cardiovascular disease. Effector T cells such as T-helper (Th) 1 (interferon-γ-producing) and Th2 lymphocytes (that produce interleukin-4), as well as Th17 (that produce interleukin-17), and T suppressor lymphocytes including regulatory T cells (Treg), which express the transcription factor forkhead box P3 (Foxp3), are involved in the remodelling of small arteries that occurs under the action of angiotensin II, deoxycorticosterone-salt and aldosterone-salt, as well as in models of hypertension such as the Dahl-salt-sensitive rat. The mechanism whereby the immune system is activated is unclear, but it has been suggested that neo-antigens may be generated by the elevation of blood pressure or other stimuli, leading to the activation of the immune response. Activated Th1 may contribute to vascular remodelling directly on blood vessels via effects of the cytokines produced or indirectly by actions on the kidney. The protective effect of Treg may be mediated similarly directly or via renal effects. These data offer promise for the discovery of new therapeutic targets to ameliorate vascular remodelling, which could lead to improved outcome in cardiovascular disease in humans.


Subject(s)
Arterioles/immunology , Arterioles/pathology , Hypertension/immunology , Hypertension/pathology , Immunomodulation , Vascular Resistance , Animals , Arteries/anatomy & histology , Arteries/immunology , Arteries/pathology , Arterioles/anatomy & histology , Cytokines/blood , Cytokines/metabolism , Humans , Hypertension/blood , Hypertension/metabolism , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism
14.
Atherosclerosis ; 219(2): 579-87, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21872249

ABSTRACT

OBJECTIVES: Optical coherence tomography (OCT) is a high resolution imaging technique used to assess superficial atherosclerotic plaque morphology. Utility of OCT may be enhanced by contrast agents targeting molecular mediators of inflammation. METHODS AND RESULTS: Microparticles of iron oxide (MPIO; 1 and 4.5 µm diameter) in suspension were visualized and accurately quantified using a clinical optical coherence tomography system. Bound to PECAM-1 on a plane of cultured endothelial cells under static conditions, 1 µm MPIO were also readily detected by OCT. To design a molecular contrast probe that would bind activated endothelium under conditions of shear stress, we quantified the expression (basal vs. TNF-activated; molecules µm(-2)) of VCAM-1 (not detected vs. 16 ± 1); PECAM-1 (132 ± 6 vs. 198 ± 10) and E-selectin (not detected vs. 46 ± 0.6) using quantitative flow cytometry. We then compared the retention of antibody-conjugated MPIO targeting each of these molecules plus a combined VCAM-1 and E-selectin (E+V) probe across a range of physiologically relevant shear stresses. E+V MPIO were consistently retained with highest efficiency (P < 0.001) and at a density that provided conspicuous contrast effects on OCT pullback. CONCLUSION: Microparticles of iron oxide were detectable using a clinical OCT system. Assessment of binding under flow conditions recommended an approach that targeted both E-selectin and VCAM-1. Bound to HUVEC under conditions of flow, targeted 1 µm E+V MPIO were readily identified on OCT pullback. Molecular imaging with OCT may be feasible in vivo using antibody targeted MPIO.


Subject(s)
Coronary Vessels/metabolism , Ferric Compounds/metabolism , Human Umbilical Vein Endothelial Cells/metabolism , Molecular Imaging/methods , Molecular Probes , Tomography, Optical Coherence , Animals , Antibodies, Monoclonal/metabolism , Arterioles/immunology , Arterioles/metabolism , Biomarkers/metabolism , Cells, Cultured , Coronary Vessels/immunology , E-Selectin/immunology , E-Selectin/metabolism , Flow Cytometry , Human Umbilical Vein Endothelial Cells/immunology , Humans , Immunohistochemistry , Inflammation Mediators/immunology , Inflammation Mediators/metabolism , Ligands , Male , Microscopy, Fluorescence , Microscopy, Video , Particle Size , Platelet Endothelial Cell Adhesion Molecule-1/immunology , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Protein Binding , Rats , Rats, Wistar , Research Design , Stress, Mechanical , Tumor Necrosis Factor-alpha/metabolism , Vascular Cell Adhesion Molecule-1/immunology , Vascular Cell Adhesion Molecule-1/metabolism
15.
Intern Med ; 50(14): 1465-9, 2011.
Article in English | MEDLINE | ID: mdl-21757831

ABSTRACT

We describe a 60-year-old man with IgG4-related chronic sclerosing dacryoadenitis and sialoadenitis associated with lymphoplasmacytic and eosinophilic infiltration in erythematous nodules. Physical examination revealed left eye extrusion and small itchy nodules on the scalp and neck. The serum IgG level was 1,570 mg/dL, IgG4 463 mg/dL (29.5%), and IgE 4,554 IU/mL. Lacrimal gland biopsy disclosed prominent infiltrates of IgG4-positive plasma cells and scattered eosinophilic infiltrates with fibrosis, consistent with IgG4-related disease. A skin biopsy of a cutaneous nodule demonstrated that the infiltrated plasma cells around arterioles or venules in the deep dermis and subcutaneous fat tissue were strongly positive for IgG4. Although the swollen lacrimal and parotid gland and itchy subcutaneous erythematous nodules improved rapidly with oral prednisolone at a dose of 20 mg per day, the skin, lacrimal, and parotid lesions deteriorated simultaneously during steroid tapering and improved after increasing the dosage. As skin lesions are easy to biopsy, further study of the skin manifestations of IgG4-related disease will be important in further clarifying the clinical spectrum, pathophysiology and response to therapy of this disorder.


Subject(s)
Dacryocystitis/immunology , Dacryocystitis/pathology , Immunoglobulin G/metabolism , Sialadenitis/immunology , Sialadenitis/pathology , Skin/immunology , Skin/pathology , Arterioles/immunology , Arterioles/pathology , Autoimmune Diseases/complications , Autoimmune Diseases/immunology , Autoimmune Diseases/pathology , Chronic Disease , Dacryocystitis/complications , Diagnosis, Differential , Eosinophils/pathology , Humans , Lymphocytes/pathology , Male , Middle Aged , Plasma Cells/immunology , Plasma Cells/pathology , Sclerosis , Sialadenitis/complications , Skin/blood supply , Venules/immunology , Venules/pathology
16.
Am J Pathol ; 178(1): 434-41, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21224080

ABSTRACT

Coronary artery disease in patients with hypertension is increasing worldwide and leads to severe cardiovascular complications. The cellular and molecular mechanisms that underlie this pathologic condition are not well understood. Experimental and clinical research indicates that immune cells and inflammation play a central role in the pathogenesis of cardiovascular diseases. Recently, it has been reported that CD4(+)CD25(+) regulatory T cells (Tregs) regulate heart fibrosis in hypertension. In this study, we determined the role of Tregs in coronary arteriolar endothelial dysfunction in angiotensin II-dependent hypertensive mice. Mice infused with angiotensin II had significantly increased blood pressure, as determined using telemetry, and apoptotic Treg numbers, as measured using flow cytometry. The mice displayed inflammation, assessed by macrophage activation/infiltration into coronary arterioles and the heart, and increased local tumor necrosis factor-α release, which participates in reduced coronary arteriolar endothelial-dependent relaxation in response to acetylcholine using an arteriograph. Hypertensive mice injected with Tregs isolated from control mice had significantly reduced macrophage activation and infiltration, reduced tumor necrosis factor-α release, and improved coronary arteriolar endothelium-dependent relaxation. Our novel data indicate that Tregs are important in the development of coronary arteriolar endothelial dysfunction in hypertension. These results suggest a new direction in the investigation of vascular disease in hypertension and could lead to a therapeutic strategy that involves immune system modulation using Tregs.


Subject(s)
Coronary Vessels/physiopathology , Endothelium, Vascular/physiopathology , Hypertension/physiopathology , T-Lymphocytes, Regulatory/immunology , Animals , Arterioles/immunology , Arterioles/physiopathology , Coronary Vessels/immunology , Endothelium, Vascular/immunology , Hypertension/immunology , Lymphocyte Count , Macrophages/immunology , Male , Mice , Mice, Inbred C57BL
17.
Thromb Haemost ; 104(6): 1184-92, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20838746

ABSTRACT

Lymphocytes are present in atherosclerotic lesion. We hypothesise that platelets may facilitate lymphocyte infiltration into the arterial wall. Reconstituted human blood or whole blood was perfused through a collagen-coated parallel-plate flow chamber at different shear rates. Adhered platelets markedly enhanced lymphocyte adhesion that increased lymphocyte deposition from 10 ± 3 cells/mm2 of platelet-depleted blood to 38 ± 11 cells/mm2 of platelet-containing blood at the arterial shear rate of 500 s-1. Platelet-dependent lymphocyte adhesion was inhibited by P-selectin, CD40L, and GPIIb/IIIa-blocking agents, suggesting the involvement of multiple adhesion molecules in this heterotypic interaction. Lymphocyte deposition was more marked among T cells, and seen in both small and large cells. B and natural killer cell adhesion was, however, mainly seen in small cells. Platelet-conjugation facilitated lymphocyte adhesion, as suggested by the selective deposition of platelet-conjugated lymphocytes. In a mouse model of arterial thrombosis, FeCl3-induced thrombus formation markedly enhanced lymphocyte adhesion and infiltration into platelet thrombi, which was abolished by GPIIb/IIIa inhibition. In conclusion, platelets support lymphocyte adhesion under arterial flow conditions, which is selective among T cells and involves multiple adhesion molecules. Our data imply that platelets may facilitate the recruitment of circulating lymphocytes at the arterial injured sites.


Subject(s)
Blood Platelets/immunology , Leukocyte Rolling , Mesentery/blood supply , Platelet Adhesiveness , T-Lymphocytes/immunology , Thrombosis/immunology , Adult , Animals , Antibodies, Monoclonal/pharmacology , Arterioles/immunology , B-Lymphocytes/immunology , Blood Platelets/drug effects , Blood Platelets/metabolism , CD40 Ligand/antagonists & inhibitors , CD40 Ligand/metabolism , Chlorides , Collagen/metabolism , Disease Models, Animal , Female , Ferric Compounds , Humans , Killer Cells, Natural/immunology , Leukocyte Rolling/drug effects , Male , Mice , Mice, Inbred C57BL , Middle Aged , P-Selectin/antagonists & inhibitors , P-Selectin/metabolism , Platelet Adhesiveness/drug effects , Platelet Aggregation Inhibitors/pharmacology , Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors , Platelet Glycoprotein GPIIb-IIIa Complex/metabolism , Stress, Mechanical , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Thrombosis/blood , Thrombosis/chemically induced , Time Factors , Young Adult
18.
Am J Pathol ; 177(4): 2134-44, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20802174

ABSTRACT

Cytomegalovirus (CMV) persistently infects more than 60% of the worldwide population. In immunocompetent hosts, it has been implicated in several diseases, including cardiovascular disease, possibly through the induction of inflammatory pathways. Cardiovascular risk factors promote an inflammatory phenotype in the microvasculature long before clinical disease is evident. This study determined whether CMV also impairs microvascular homeostasis and synergizes with hypercholesterolemia to exaggerate these responses. Intravital microscopy was used to assess endothelium-dependent and -independent arteriolar vasodilation and venular leukocyte and platelet adhesion in mice after injection with either mock inoculum or murine CMV (mCMV). Mice were fed a normal (ND) or high-cholesterol (HC) diet beginning at 5 weeks postinfection (p.i.), or a HC diet for the final 4 weeks of infection. mCMV-ND mice exhibited impaired endothelium-dependent vasodilation versus mock-ND at 9 and 12 weeks and endothelium-independent arteriolar dysfunction by 24 weeks. Transient mild leukocyte adhesion occurred in mCMV-ND venules at 7 and 21 weeks p.i. HC alone caused temporary arteriolar dysfunction and venular leukocyte and platelet recruitment, which were exaggerated and prolonged by mCMV infection. The time of introduction of HC after mCMV infection determined whether mCMV+HC led to worse venular inflammation than either factor alone. These findings reveal a proinflammatory influence of persistent mCMV on the microvasculature, and suggest that mCMV infection enhances microvasculature susceptibility to both inflammatory and thrombogenic responses caused by hypercholesterolemia.


Subject(s)
Arterioles/pathology , Cytomegalovirus Infections/immunology , Cytomegalovirus/pathogenicity , Endothelium, Vascular/pathology , Hypercholesterolemia/immunology , Venules/pathology , Animals , Arterioles/immunology , Cell Adhesion , Cholesterol/administration & dosage , Cholesterol/blood , Cytomegalovirus Infections/virology , DNA, Viral/genetics , Endothelium, Vascular/immunology , Hypercholesterolemia/pathology , Hypercholesterolemia/virology , Inflammation/etiology , Inflammation/pathology , Mice , Mice, Inbred C57BL , NIH 3T3 Cells , Platelet Adhesiveness/immunology , Polymerase Chain Reaction , Vasodilation , Venules/immunology
19.
Cardiovasc Res ; 87(4): 740-50, 2010 Sep 01.
Article in English | MEDLINE | ID: mdl-20484220

ABSTRACT

AIMS: Bone marrow (BM) progenitor cells may contribute to vascular remodelling. The present study aimed to investigate the contribution of BM-derived CXCR4(+) (a CXC chemokine receptor) and PDGFRbeta(+) (platelet-derived growth factor receptor beta) progenitor cells in hypoxia-induced muscularization of alveolar arterioles. METHODS AND RESULTS: Accumulation of GFP(+) (green fluorescent protein) cells was markedly increased in the pulmonary vasculature by the hypoxic (10% O(2,) 4 weeks) chimeric mice with transgenic GFP-tagged BM. After injection of BM-derived CXCR4(+)/PDGFRbeta(+) progenitor cells into C57BL/6J mice, followed by 6-week hypoxia, the cells were found to home to the alveolar arterioles and readily differentiated into smooth muscle cells (SMCs). Under the same hypoxic conditions, mice infused with myocardin lentiviral RNAi vector-transduced progenitor cells displayed lower myocardin expression in the muscularized alveolar arterioles, correlating with decreased pulmonary artery pressure and arteriole muscularization. In vitro experiments further confirmed that the differentiation of the progenitor cells into SMCs occurred under hypoxia (1% O(2)), and SMC differentiation could be suppressed when myocardin RNAi was administered. CONCLUSION: Theses results suggest that myocardin may contribute to the differentiation of CXCR4(+)/PDGFRbeta(+) progenitor cells into SMCs induced by hypoxia, which leads to the muscularization of alveolar arterioles.


Subject(s)
Bone Marrow Cells/metabolism , Bone Marrow Transplantation , Hypoxia/metabolism , Muscle, Smooth, Vascular/metabolism , Nuclear Proteins/metabolism , Pulmonary Alveoli/blood supply , Receptor, Platelet-Derived Growth Factor beta/metabolism , Receptors, CXCR4/metabolism , Stem Cell Transplantation , Stem Cells/metabolism , Trans-Activators/metabolism , Animals , Arterioles/immunology , Arterioles/metabolism , Blood Pressure , Bone Marrow Cells/immunology , Cell Differentiation , Cell Movement , Disease Models, Animal , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Hypoxia/immunology , Hypoxia/physiopathology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Muscle, Smooth, Vascular/immunology , NIH 3T3 Cells , Nuclear Proteins/genetics , RNA Interference , Stem Cells/immunology , Time Factors , Trans-Activators/genetics , Transplantation Chimera
20.
Nihon Jinzo Gakkai Shi ; 52(2): 147-53, 2010.
Article in Japanese | MEDLINE | ID: mdl-20415236

ABSTRACT

Various renal vascular lesions are complicated with systemic lupus erythematosus (SLE), and are often overlooked in the actual renal biopsy specimen. We report a case of biopsy-proven lupus vasculopathy, with lupus nephritis class IV-G (A). She developed SLE at 15 years of age, and was treated with prednisolone(PSL) and cyclophosphamide (CTX). Sometimes she experienced a flare-up clinically or serologically, requiring a dose increase of oral PSL. At 40 years of age, she visited our hospital after discontinuation of hospital visits for about 4 months. Oral PSL at 30 mg per day was not effective for urinary abnormalities, increase of anti double-stranded DNA (ds-DNA) antibody titer and decrease in complement components. On admission she had hypertension (180/92 mmHg) and signs of microangiopathic hemolytic anemia. Renal biopsy findings showed the glomerular changes of lupus nephritis, WHO class IV-G (A), and lupus vasculopathy, which is marked luminal narrowing or total occlusion by abundant subendothelial accumulation of immunoglobulins and complement components. In addition to PSL, intravenous pulse CTX promptly achieved clinical remission. When lupus vasculopathy is complicated, CTX may be useful.


Subject(s)
Arterioles/immunology , Kidney/blood supply , Lupus Nephritis/etiology , Adult , Complement System Proteins/metabolism , Cyclophosphamide/administration & dosage , Female , Humans , Immunoglobulins/metabolism , Infusions, Intravenous , Lupus Erythematosus, Systemic/complications , Lupus Nephritis/diagnosis , Lupus Nephritis/drug therapy , Lupus Nephritis/immunology , Prednisolone/therapeutic use , Pulse Therapy, Drug , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...